Kua Khai Loon
SEC insider (Form 3/4/5 filer). CIK 0002081556. 10% Owner at Cyclacel Pharmaceuticals, Inc. (CYCC). 8 reported Form 4/5 transactions since Sep 2024; latest on Nov 5, 2025. Located in JOHOR BAHRU, N8.
Companies Kua Khai Loon has filed insider reports for
- Cyclacel Pharmaceuticals, Inc. (CYCC): 10% Owner
Kua Khai Loon
CIK: 0002081556
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cyclacel Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Nov 5, 2025BGMS
Bio Green Med Solution, Inc.
OtherDirect467.5K shares- - Oct 30, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect242.5K shares at avg. $1.80$436K - Oct 16, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect88.2K shares at avg. $4.22$372K - Oct 15, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect7.5K shares at avg. $5.66$42K - Sep 16, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect25K shares at avg. $5.13$128K - Sep 12, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect22.3K shares at avg. $6.22$138K - Sep 5, 2025CYCC
Cyclacel Pharmaceuticals, Inc.
SaleDirect19.1K shares at avg. $7.01$134K - Sep 4, 2025CYCC
Cyclacel Pharmaceuticals, Inc.
OtherDirect186.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 5, 2025 |  BGMS Bio Green Med Solution, Inc. | Other | 467,535 | - | - | Direct |
| Oct 30, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 242,477 | $1.80 | $436,459 | Direct |
| Oct 16, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 88,204 | $4.22 | $371,956 | Direct |
| Oct 15, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 7,479 | $5.66 | $42,339 | Direct |
| Sep 16, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 25,000 | $5.13 | $128,300 | Direct |
| Sep 12, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 22,251 | $6.22 | $138,490 | Direct |
| Sep 5, 2025 | CYCC Cyclacel Pharmaceuticals, Inc. | Sale | 19,054 | $7.01 | $133,569 | Direct |
| Sep 4, 2025 | CYCC Cyclacel Pharmaceuticals, Inc. | Other | 186,465 | - | - | Direct |
1-8 of 8 transactions